Graham Capital Management’s Clover Health Investments CLOV Stock Holding History

Graham Capital Management’s Portfolio CLOV Stock Details CLOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-110,863	Closed	-$261K	–	1211
2025 Q4	$261K	Buy	+110,863	New	+$303K	0.01%	927
2025 Q3	–	Sell	-238,245	Closed	-$665K	–	1297
2025 Q2	$665K	Sell	238,245 -30,215	-11%	-$99.3K	0.01%	712
2025 Q1	$964K	Sell	268,460 -13,804	-5%	-$55.4K	0.02%	562
2024 Q4	$889K	Buy	+282,264	New	+$1.01M	0.01%	530
2024 Q2	–	Sell	-26,600	Closed	-$21.1K	–	1082
2024 Q1	$21.1K	Buy	26,600 +11,376	+75%	+$10.4K	﹤0.01%	1026
2023 Q4	$14.5K	Buy	+15,224	New	+$14.9K	﹤0.01%	959
2023 Q2	–	Sell	-115,549	Closed	-$97.7K	–	1000
2023 Q1	$97.7K	Buy	+115,549	New	+$126K	﹤0.01%	1004
2022 Q4	–	Sell	-713,063	Closed	-$1.21M	–	1081
2022 Q3	$1.21M	Sell	713,063 -808,429	-53%	-$2.12M	0.05%	401
2022 Q2	$3.25M	Buy	1,521,492 +1,480,098	+3,576%	+$3.93M	0.13%	102
2022 Q1	$146K	Sell	41,394 -15,837	-28%	-$45.9K	0.01%	847
2021 Q4	$212K	Buy	+57,231	New	+$351K	0.01%	447

Other funds holding CLOV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Graham Capital Management's CLOV Position: Q1 2026 in Review

Graham Capital Management sold out of Clover Health Investments (CLOV) in Q1 2026, closing a stake of 110,863 shares — an estimated $261K sold.

Graham Capital Management first reported a position in CLOV in Q4 2021 and held it in 11 quarters. The position peaked at $3.25M in Q2 2022. 208 funds tracked by Wall St. Rank hold CLOV as of Q1 2026.

Graham Capital Management reported no remaining Clover Health Investments position as of Q1 2026 after selling out during the quarter.
Graham Capital Management sold 110,863 Clover Health Investments shares in Q1 2026, an estimated $261K.
Graham Capital Management first reported a position in Clover Health Investments in Q4 2021 and held it in 11 quarters.
Graham Capital Management's Clover Health Investments position peaked at $3.25M in Q2 2022.
208 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2026.

Based on Graham Capital Management's 13F filing for Q1 2026, filed 15 May 2026.